Alzheimer's Disease/Cognition News

Current use of antidepressants corresponded with faster cognitive decline in older adults with dementia, a cohort analysis published in BMC Medicine indicated.

Older adults with cancer had a lower risk for Alzheimer’s disease and related dementias than cancer-free individuals of the same age, according to results of a longitudinal retrospective study.

Phosphorylated tau 217 better detected Alzheimer’s disease pathology across a range of neurodegenerative syndromes compared with other plasma blood-based biomarkers, data from a study in JAMA Neurology show.

The effect of levetiracetam, an antiseizure therapy, on high-frequency oscillation in patients with Alzheimer’s disease as well as epilepsy may prove its viability as a biomarker of disease pathology, according to data.

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health issues, recent data suggest they may improve brain health.

A blood-based biomarker test may be a reliable method for predicting or ruling out Alzheimer’s disease-related pathology and subsequently for assisting clinicians in formulating a treatment plan for patients, according to new research.

Older adults with Alzheimer’s disease and related dementias faced a greater risk for hospitalization after being continuously exposed to extreme heat, results from a cohort study showed.

Prolonged rapid eye movement sleep latency may be an early indicator of Alzheimer’s disease and related dementias, according to research conducted in China and published in Alzheimer’s & Dementia.

In a small cohort of adults in South Korea, the presence of cerebral small vessel disease was associated with color reading and visual deficits, but not memory, across an 8-year follow-up interval, according to new research.